NASDAQ: EVO
Evotec Se Stock Ownership - Who owns Evotec Se?

Insider buying vs selling

Have Evotec Se insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when EVO insiders and whales buy or sell their stock.

EVO Shareholders

What type of owners hold Evotec Se stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Mubadala Investment Co Pjsc2.59%4,597,701$16.83MInstitution
Wellington Management Group LLP0.80%1,429,899$5.23MInstitution
Blackrock Inc0.73%1,300,009$4.76MInstitution
Dcf Advisers LLC0.67%1,198,993$4.39MInstitution
Morgan Stanley0.18%314,912$1.15MInstitution
Wcm Investment Management LLC0.17%300,277$1.10MInstitution
Pitcairn Co0.09%161,769$592.07kInstitution
Abc Arbitrage Sa0.07%132,057$483.33kInstitution
Citadel Advisors LLC0.05%96,045$351.52kInstitution
Envestnet Asset Management Inc0.04%75,711$277.10kInstitution

1 of 3

EVO vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EVO5.56%0.00%
COLL51.95%48.05%Net SellingNet Selling
AMPH48.29%51.71%Net BuyingNet Selling
PAHC43.60%56.40%Net SellingNet Selling
HROW28.80%71.20%Net SellingNet Buying

Evotec Se Stock Ownership FAQ

Who owns Evotec Se?

Evotec Se (NASDAQ: EVO) is owned by 5.56% institutional shareholders, 0.00% Evotec Se insiders, and 94.44% retail investors. Mubadala Investment Co Pjsc is the largest individual Evotec Se shareholder, owning 4.60M shares representing 2.59% of the company. Mubadala Investment Co Pjsc's Evotec Se shares are currently valued at $17.43M.

If you're new to stock investing, here's how to buy Evotec Se stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.